Company Filing History:
Years Active: 2017-2023
Title: Discovering the Innovations of Eric C. Scribben
Introduction
Eric C. Scribben, an inventive mind based in Springfield, OH, has made significant contributions to the field of medical technology through his innovative approaches to drug delivery systems. With three registered patents to his name, Scribben has focused on enhancing therapeutic applications, making medical treatments more effective and patient-friendly.
Latest Patents
One of Eric C. Scribben's notable patents involves processes for the delivery of viscous drug therapies. This innovative approach utilizes core annular flow to enable the subcutaneous delivery of viscous fluids, such as protein therapeutic formulations. In this process, the high-viscosity fluid is enveloped by a low-viscosity fluid, which facilitates the smooth passage of the thicker substance. This method allows for the administration of protein formulations with higher concentrations and viscosities, reducing injection forces and times significantly. Various embodiments of injection devices that provide core annular flow are described, showcasing the versatility of this approach.
Career Highlights
Eric C. Scribben’s career is highlighted by his position at Battelle Memorial Institute, where he applies his innovative ideas in developing cutting-edge solutions in drug delivery technologies. His work at Battelle has positioned him as an influential figure in medical research, contributing to advancements that enhance patient care.
Collaborations
Throughout his career, Scribben has collaborated with talented individuals including colleagues Steven Risser and Amy M. Heintz. These partnerships have fostered a collaborative environment that promotes innovative thinking and the successful execution of complex projects in the field of therapeutic delivery.
Conclusion
Eric C. Scribben's contributions reflect his dedication to improving medical treatments through innovation. His patents and collaborative efforts demonstrate how inventive technologies can lead to enhanced patient outcomes. As he continues to explore new frontiers in drug delivery, his work represents a significant advancement in the medical community.